Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02507570
Title Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Carolina Research Professionals, LLC

prostate cancer



Radium Ra 223 dichloride

Age Groups: adult
Covered Countries USA

No variant requirements are available.